Literature DB >> 6127359

Delayed pressure urticaria.

G L Sussman, R P Harvey, A L Schocket.   

Abstract

Delayed pressure urticaria (DPU) is a poorly understood syndrome. We describe 17 patients with DPU. Chronic urticaria was present in 94%. All had negative challenges for immediate demographism and cold urticaria. DPU was induced with a pressure challenge on the shoulder of 15 pounds for 15 min. Average onset of pressure lesions after challenge was 6.5. Lesions were painful, not pruritic, peaked at 9 hr, and disappeared by 24 to 48 hr. Fever, chills, and/or arthralgias occurred in 78%. Positive laboratory abnormalities included leukocytosis in 20% and elevated erythrocyte sedimentation rate in 37.5%. Skin biopsies of lesions showed perivascular round cell infiltrates and negative immunofluorescence. Urticaria responded to antihistamines, but not aspirin, in 100% of patients, while pressure lesions improved with nonsteroidal anti-inflammatory drugs (NSAID), but not antihistamines, in 80% of patients. Both urticaria and DPU were controlled with prednisone, which was necessary in 87.5% of patients. A severe nonremitting course was noted in 7%, 40% had a moderate remitting course requiring intermittent prednisone, and 53% had a mild remitting disease requiring no medication or antihistamines and/or NSAID only. We conclude that DPU is more common than previously appreciated and likely involves mediators other than histamine, possibly the prostaglandin system.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127359     DOI: 10.1016/0091-6749(82)90022-7

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  12 in total

Review 1.  Treatment of patients with chronic idiopathic urticaria.

Authors:  Brett E Stanaland
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

2.  Late Dysphagia and dyspnea as complications of esophagogastroduodenoscopy in delayed pressure urticaria: case report.

Authors:  E Czecior; A Grzanka; J Kurak; M Misiolek; A Kasperska-Zajac
Journal:  Dysphagia       Date:  2011-06-05       Impact factor: 3.438

Review 3.  Histamine2 (H2)-receptor antagonists in the treatment of urticaria.

Authors:  T C Theoharides
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

Review 4.  Chronic urticaria: aetiology, management and current and future treatment options.

Authors:  Martina M A Kozel; Ruth A Sabroe
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  The urticarias. Current concepts in pathogenesis and treatment.

Authors:  K P Mathews
Journal:  Drugs       Date:  1985-12       Impact factor: 9.546

6.  The effects of topical corticosteroids on delayed pressure urticaria.

Authors:  R J Barlow; D M Macdonald; A K Black; M W Greaves
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 7.  Evaluating chronic urticaria patients for allergies, infections, or autoimmune disorders.

Authors:  Y C Wai; Gordon L Sussman
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

Review 8.  [Urticaria and antihistamines].

Authors:  J Tousignant; B Côté; D Barolet
Journal:  Can Fam Physician       Date:  1993-01       Impact factor: 3.275

Review 9.  Physical allergies and exercise. Clinical implications for those engaged in sports activities.

Authors:  W W Briner
Journal:  Sports Med       Date:  1993-06       Impact factor: 11.136

Review 10.  [Urticaria … and treatment fails].

Authors:  B Wedi; D Wieczorek; U Raap; A Kapp
Journal:  Hautarzt       Date:  2013-09       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.